Cadila Healthcare Limited Carvedilol Export Data — India (DGFT 2022–2026)

Name: Cadila Healthcare Limited Carvedilol Export Records India — #8 Exporter, 74 Shipments, $3.0M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Carvedilol

India Pharmaceutical Trade Intelligence

$98.1M242 Suppliers98 CountriesHS 30049079

ExportsIndia → UNITED STATES60.1%India → ECUADOR16.5%

ImportsUNITED STATES → India$74.1K CANADA → India$35.1K

#1 Supplier: ZYDUS LIFESCIENCES #1 Buyer: EVERSANA LIFE

Cadila Healthcare Limited — Carvedilol Exporter #8 | $4.9M Trade Value | TransData Nexus | TransData Nexus

Cadila Healthcare Limited — Carvedilol Exporter Profile

Indian Pharmaceutical Exporter · #8 for Carvedilol · $4.9M export value · DGFT Verified

Cadila Healthcare Limited is the #8 Indian exporter of Carvedilol with $4.9M in export value and 74 verified shipments. Cadila Healthcare Limited holds a 3.1% market share in Carvedilol exports across 2 countries. The company exports 41 pharmaceutical products worth $34.9M across 17 therapeutic categories.

Cadila Healthcare Limited — Carvedilol Export Profile: Buyers & Destinations

Cadila Healthcare Limited Carvedilol export treemap — buyers and destination countries | TransData Nexus

Where Does Cadila Healthcare Limited Export Carvedilol?

Country	Value	Shipments	Share
UNITED STATES	$3.4M	98	96.4%
SRI LANKA	$124.1K	14	3.6%

Cadila Healthcare Limited exports Carvedilol to 2 countries. The largest destination is UNITED STATES accounting for 96.4% of Cadila Healthcare Limited's Carvedilol shipments. These destinations reflect Cadila Healthcare Limited's established distribution network and regulatory approvals in key markets.

Who Are the Top Buyers of Carvedilol from Cadila Healthcare Limited?

What Carvedilol Formulations Does Cadila Healthcare Limited Export?

Product Description / Formulation	Value	Shipments
CARVEDILOL 25MG TABS 1X500 DIST. NDC - 68382-095-05 MANUFACTURING . NDC - 65841-619-05 ASPER INVOICE. & P.LIST	$100.0K	2
CARVEDILOL TAB USP 12.5 MG - 1 X 500NDC- 68001-151-03B.NO Z302338 MANUFACTURING .DT. 05/2023 EXP.DT. 04/2025	$99.7K	2
CARVEDILOL 25MG TABLETS [1X500 PER PACK]	$77.8K	2
CARVEDILOL 25MG TABS 1X500 DIST. NDC - 6	$69.6K	2
CARVEDILOL TAB USP 12.5 MG-1X500 NDC-68001-151-03 B/N.Z302337 MANUFACTURING -05/2023EXP-04/2025	$63.1K	2
CARVEDILOL TAB USP 25 MG-1X500 NDC-68001-152-03 B/N.Z302326 MANUFACTURING -05/2023EXP-04/2025	$58.6K	2
CARVEDILOL TAB USP 25 MG - 1 X 500NDC -68001-152-03B.NO Z302325 MANUFACTURING .DT. 05/2023 EXP.DT. 04/2025	$57.7K	2
PHARMA MEDICINE FOR HUMAN USE-CARVEDILOL 25MG TABS 1X500-QTY-2904.000 PAC-AS PER INV	$55.7K	3
CARVEDILOL TABLETS 12.5 MG-1X500 NDC-82009-127-05,B/N. Z303689,Z303690 MANUFACTURING .DT. 07/2023 EXP.DT. 06/2025	$50.0K	1
PHARMA MEDICINE FOR HUMAN USE-CARVEDILOL 6.25MG TABS 1X500-QTY-18,996.000 PAC-AS PER INV	$50.0K	1

Cadila Healthcare Limited exports 94 distinct Carvedilol formulations including tablets, capsules, syrups, and combination drugs. The top formulation is CARVEDILOL 25MG TABS 1X500 DIST. NDC - 68382-095-05 MANUFAC with 2 shipments worth $100.0K.

How Does Cadila Healthcare Limited Compare to Nearest Carvedilol Exporters?

Exporters ranked immediately above and below #8 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
3	PIRAMAL PHARMA LIMITED	$7.0M	141	1	$50.0K
7	RUBICON RESEARCH PRIVATE LIMITED	$6.6M	199	1	$33.0K
8	CADILA HEALTHCARE LIMITED ★	$3.0M	74	2	$40.5K
9	AUROBINDO PHARMA LIMITED	$2.0M	184	12	$11.1K
10	RUBICON RESEARCH LIMITED	$2.0M	69	1	$29.4K

Cadila Healthcare Limited ranks #8 among 242 Indian Carvedilol exporters. Average shipment value of $40.5K compared to the market average of $277.3K. The closest competitors by value are PIRAMAL PHARMA LIMITED and RUBICON RESEARCH PRIVATE LIMITED.

Which Indian Ports Ship Carvedilol Exports?

Port	Shipments	% Share
NHAVA SHEVA SEA (INNSA1)	506	10.7%
SAHAR AIR	482	10.1%
DELHI AIR CARGO ACC (INDEL4)	405	8.5%
SAHAR AIR CARGO ACC (INBOM4)	358	7.5%
MUNDRA SEA	305	6.4%
DELHI AIR	288	6.1%
HYDERABAD ICD (INSNF6)	253	5.3%
JNPT/ NHAVA SHEVA SEA	238	5.0%

Geopolitical & Trade Policy Impact on Cadila Healthcare Limited's Carvedilol Exports

The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Zydus. The escalating conflict in the Middle East has disrupted key maritime routes, particularly the Red Sea and Suez Canal, leading to longer transit times and increased freight costs. Major carriers have suspended or restricted transits, extending transit times by 10–20 days and raising freight rates by 40–50% on key India–Europe routes. (livemint.com) This situation poses significant challenges for time-sensitive pharmaceutical shipments, especially temperature-sensitive medicines. (economictimes.indiatimes.com)

Conversely, U.S.–China trade tensions have prompted the U.S. to impose tariffs on Chinese pharmaceutical imports, creating an opportunity for Indian exporters to fill the supply gap. However, the U.S. has also introduced tariffs on Indian imports, including a 25% "reciprocal" tariff, followed by an additional 25% penalty tied to India's continued imports of Russian oil, bringing the total duty to 50%. (en.wikipedia.org) While pharmaceuticals are currently exempt, the potential for future tariffs necessitates strategic planning.

In the European Union, compliance with the Falsified Medicines Directive (FMD) is crucial. The FMD mandates stringent serialization and traceability requirements to prevent counterfeit medicines from entering the supply chain. Non-compliance can result in restricted market access, making adherence to these regulations imperative for exporters like Zydus.

Cadila Healthcare Limited — Regulatory Compliance & Quality Standards

Maintaining compliance with international regulatory standards is paramount for Indian pharmaceutical exporters. The U.S. FDA, WHO, and EU Good Manufacturing Practice (GMP) guidelines set stringent quality benchmarks. Any lapses can lead to import alerts, product recalls, or facility shutdowns. For instance, in 2019, Zydus's Moraiya facility received an Official Action Indicated (OAI) classification from the U.S. FDA, indicating that regulatory and/or administrative actions were recommended. (moneycontrol.com) Such events underscore the importance of robust quality assurance systems.

The evolving regulatory landscape demands continuous investment in compliance infrastructure. The EU's Falsified Medicines Directive and the U.S. Drug Supply Chain Security Act (DSCSA) require advanced serialization and traceability measures. Non-compliance can result in restricted market access, making adherence to these regulations imperative for exporters like Zydus.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Carvedilol shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Cadila Healthcare Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 112 individual customs records matching Cadila Healthcare Limited exporting Carvedilol, covering 94 formulations to 2 countries via 6 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 98+ countries, 529+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

EVERSANA LIFE SCIENCE SERVICES	UNITED STATES	$2.3M	62
AMERISOURCE HEALTH SERVICES DBA AMERICAN HEALTH	UNITED STATES	$835.1K	29
PRIORITY HEALTHCARE DISTRIBUTION DBA	UNITED STATES	$258.1K	7
SUNSHINE HEALTHCARE LANKA LIMITED	SRI LANKA	$65.2K	9
STATE PHARMACEUTICALS CORPORATION	SRI LANKA	$52.2K	4
STATE PHARMACEUTICALS COLOMBO	SRI LANKA	$6.7K	1

Carvedilol

Carvedilol

Cadila Healthcare Limited — Carvedilol Exporter Profile

Cadila Healthcare Limited — Carvedilol Export Profile: Buyers & Destinations

Where Does Cadila Healthcare Limited Export Carvedilol?

Who Are the Top Buyers of Carvedilol from Cadila Healthcare Limited?

What Is India's Total Carvedilol Export Value and How Much Does Cadila Healthcare Limited Contribute?

What Is the Average Shipment Value for Cadila Healthcare Limited's Carvedilol Exports?

How Does Cadila Healthcare Limited Compare to Other Indian Carvedilol Exporters?

What Carvedilol Formulations Does Cadila Healthcare Limited Export?

Regulatory Requirements: Exporting Carvedilol to Key Markets

United States — FDA

How Does Cadila Healthcare Limited Compare to Nearest Carvedilol Exporters?

Which Indian Ports Ship Carvedilol Exports?

What Other Cardiovascular Products Does Cadila Healthcare Limited Export?

Geopolitical & Trade Policy Impact on Cadila Healthcare Limited's Carvedilol Exports

Cadila Healthcare Limited — Regulatory Compliance & Quality Standards

About Cadila Healthcare Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Carvedilol Export Data from Cadila Healthcare Limited

Carvedilol Stats

Company Overview

Top Products by Cadila Healthcare Limited

Related Analysis

Need Detailed Export Data?

Data Source